In cryptorchid boys, failures in germ cell development have been clearly established. Some studies reported some abnormalities in Sertoli cells morphology but the results regarding their endocrine secretion remain controversial. To compare testicular hormone levels in young boys with and without cryptorchidism, we performed a cross-sectional hospital-based study. From surgery appointment records, we identified a case group of boys with unilateral or bilateral cryptorchidism and a control group undergoing dental care, minor osteoarticular or dermal surgery. Blood samples were withdrawn during the surgical procedure to perform testosterone, inhibin B and anti-m€ ullerian hormone (AMH) immunoassays. We included 27 cryptorchid boys and 27 controls aged of 26.6 vs. 24.2 months, respectively (p = 0.172) far from the post-natal mini-puberty and the corresponding hormonal surges. Age-adjusted AMH and inhibin B levels were significantly lower in cryptorchid than in control boys (AMH: 87 ng/mL vs. 135 ng/mL; p = 0.009, inhibin B: 97 pg/mL vs. 133 pg/mL; p = 0.019, respectively). Moreover, AMH and inhibin B levels were significantly lower in the bilateral cryptorchid subgroup, being 50% lower than in the controls (p = 0.011 and 0.019, respectively) and while both hormones levels were independent in controls, they became strongly correlated in bilateral cryptorchid boys (R² = 0.75, p = 0.001). In addition, testosterone levels were still detectable in some boys, with significantly lower levels in cryptorchid group than in controls. Overall, 2-year-old cryptorchid patients presented a simultaneous and significant drop in AMH and inhibin B levels, suggesting a functional defect of Sertoli cells. This deficiency appeared more pronounced in bilateral cryptorchidism and thus, regarding the pivotal role of Sertoli cells in germ cell development, it may explain the compromised fertility found later in men born with such a malformation.
INTRODUCTION
Cryptorchidism, the most common male congenital malformation, is a complex disorder resulting from interactions between genetic and environmental factors. Epidemiological studies have identified low birth weight or intrauterine growthretardation as factors most strongly associated with cryptorchidism, with additional evidence suggesting the maternal smoking and gestational diabetes increase risk (Barthold et al., 2016) . Cryptorchidism is also a major risk factor for infertility and for testis cancer (Toppari et al., 2001; Virtanen & Toppari, 2008; McGlynn & Trabert, 2012) . To decipher its complex physiopathology, numerous studies have compared male reproductive biomarkers (Leydig cell secretion of testosterone, Sertoli cell secretion of inhibin B and anti-M€ ullerian hormone (AMH) peptides) in cryptorchid vs. non-cryptorchid boys. However, results were contradictory for testosterone, inhibin B and AMH levels with no difference being observed in the oldest studies (Christiansen et al., 2002; Barthold et al., 2004; Suomi et al., 2006) , while other studies reported lower testosterone, inhibin B and AMH levels in boys with cryptorchidism (Guibourdenche et al., 2003; Pierik et al., 2009; Matuszczak et al., 2012; Thorup et al., 2015) . These discrepancies seriously hamper the use of testicular biomarkers in cryptorchidism management and follow-up. Of interest, a recent study (Cortes et al., 2016) reported that AMH was more often below the normal range than inhibin B in a group of prepubertal cryptorchid boys (1-13 years old) and that bilateral cryptorchid had lower inhibin B and AMH than unilateral cryptorchid patients.
In order to provide more data that may help to address this question we aimed to compare reproductive hormone levels in young boys with and without cryptorchidism. Thus, we performed a cross-sectional hospital-based study of boys admitted to the paediatric surgery unit for cryptorchidism surgery and for other surgical indications.
MATERIALS AND METHODS

Study design and population recruitment
Between March 1st and December 15th, 2008, we performed a hospital-based cross-sectional study in which young boys operated for cryptorchidism (cases) were compared with young boys undergoing minor surgery (controls).
For recruitment, we used the database of patients scheduled for surgery in the paediatric surgery department of Toulouse University Hospital and selected young boys (14-32 months old) operated for cryptorchidism and for orthopaedic, dental or dermal disorders. Two groups were constituted: a case group of children with documented unilateral or bilateral congenital cryptorchidism, and a control group with no illness or urogenital malformations.
The control group underwent documented complex dental care or surgery for minor osteoarticular bone malformations (talipes, hallux valgus) or dermal malformations (cysts, naevi). All boys were examined by paediatricians to ensure that both testes were in the scrotum and that they had no urogenital malformations or urogenital tract disorders.
Based on this first list of potential cases and controls, parents were contacted and given detailed information on the study objectives and procedures. They were invited to return their signed informed consent as formal agreement to participation of their child in the study. One week before the surgery appointment, all parents were again directly contacted by phone by the research team to check that they had fully understood the information notice, to answer their questions, and to confirm or to refuse their agreement to their son's participation. The signed informed consent form was then included in the surgical and anaesthetic files.
Ethics
The study was conducted according to Helsinki II declaration and to the French law on clinical research. Informed and written consent was obtained from the parents of all individual participants included in the study. The study was approved by the French data protection authority (CNIL, no 907152) and its methodological and ethical committee (CCTIRS, favorable opinion on 06/27/2007) as well by the scientific boards of INSERM (no C08-09) and AFFSET (no EST07-09).
Complementary epidemiological data
Through paediatric records, complementary information was obtained on children's age at time of surgery, lateralization of cryptorchidism (unilateral or bilateral) for cases, and description of orthopaedic, dental or dermal disorders for controls. Children born at a gestational age of <37 weeks and those delivered by podalic version or Caesarean-section were excluded.
Blood samples and hormone analysis
After parents gave consent, blood samples were collected during the surgical procedure while the child was under anaesthesia and then transferred to the biochemistry department of the university hospital.
Testosterone was assessed using an RIA kit (Cis-Bio International, Gif-sur-Yvette, France) with a limit of quantification of 10 ng/100 mL (0.35 nmol/L) and inter-and intra-assay coefficients of variation (CVs) below 6.9% and 6.3%, respectively. Serum AMH was assayed by an enzyme-linked immunoassay (ELISA) kit (DSL-Beckman Coulter, Webster, TX, USA) with a limit of quantification of 0.05 ng/mL and inter-and intra-assay CVs of 4.6% and 8%, respectively. Serum inhibin B was measured by an ELISA kit (OBI-DSL, Oxford, UK) with a sensitivity of 15 pg/mL and inter-and intra-assay CVs below 10.2% and 3.5%, respectively. Both AMH and inhibin B were assayed in duplicate according to the manufacturer's protocols.
Statistical analysis
Survey data were stored with a unique anonymous identifier code. Statistical analyses were performed using STATA version 9 (Stata Corp., College Station, TX, USA) with statistical significance defined by two-sided p values < 0.05.
Mann-Whitney tests were used to compare the quantitative variables (age at surgery, assays) between groups. Chi-2 (v 2 ) and
Fisher exact tests were used for category comparisons between the two groups. Logistic regressions were performed to adjust pvalues for age at time of surgery.
RESULTS
Inclusion and clinical data
During the 10 months of the study period, 96 parents whose child met the inclusion criteria gave preliminary agreement for their child's participation. Of the 96 couples, 27 (28%) finally refused their son's participation. Three children were excluded as a result of premature birth. In 12 of the remaining 66 children, blood samples were not obtained for technical reasons related to the conditions of surgery. Finally, 54 children (27 cases and 27 controls) were included in this study, a participation rate of 56%. Surgery in the control group was performed for osteoarticular malformations (talipes, hallux valgus; N = 14), dental care (N = 5), and naevi and cysts (N = 8) (Fig. 1 ). Cases and controls did not differ for age at time of surgery (26.6 AE 4.7 and 24.2 AE 6.9 months respectively; p = 0.172), for gestational age at birth (39.3 AE 1.1 and 39.3 AE 1.3 weeks respectively; p = 0.45) nor for weight at birth (3.23 AE 0.38 and 3.51 AE 0.62 Kg respectively; p = 0.80). Cryptorchidism was unilateral in 63% of cases (N = 17: left-sided, 65%; right-sided, 35%) and bilateral in 37% (N = 10).
Establishing a framework for normal Sertoli cells secretion in the early infancy
As reference ranges for both AMH and inhibin B in early infancy were not provided by the immunoassays suppliers, we wanted to establish a framework for setting hormone levels of our patients. For this purpose, we searched literature for studies that provided medians or means of hormones concentrations in non-cryptorchid young boys between 1 and 5 year-old. For 784 Andrology, 2017, 5, 783-789 inhibin B (Fig 2, lower panel) , we found three articles using the OBI assay and which reported the results for 10 groups totalling 87 normal boys (mean group size = 10). For AMH (Fig. 2 , upper panel), we found two studies using an in house assay, five studies that implementing the IOT assay but none for the DSL assay. For this hormone, 14 groups were described totalling 369 control boys (mean group size = 26). From aggregated data, we observed two features of inhibin B and AMH secretion between 1 and 5 year-old. First, both hormones remained above their respective limit of quantification. Second, AMH levels declined significantly during this period (À47% according to the linear regression model), whereas inhibin B levels remained constant. Regarding our own control boys, we could confirm that their inhibin B and AMH levels laid within the normal framework of secretion. Of interest, our study provided the largest control groups to date for inhibin B.
Comparing inhibin B, AMH and testosterone secretion in normal and cryptorchid boys
For Sertoli cells hormones, as shown in Table 1 , we observed significantly different AMH and inhibin B levels between the two groups. AMH levels were 135 ng/mL in controls and 87 ng/mL in cases (p = 0.003), and inhibin B levels were 133 pg/mL in controls, decreasing to 97 pg/mL in cases (p = 0.006). These differences persisted after adjusting for age. Testosterone quantification was unexpectedly possible in 10 cases and 10 controls: it was 18.1 ng/100 mL AE 4.1 in the controls and significantly lower at 11.6 ng/100 mL AE 1.3 in the cases (p < 0.001).
We further split the 27 children with cryptorchidism into two subgroups: a group of 17 children with unilateral cryptorchidism and a group of 10 children with bilateral cryptorchidism (Table 2) . A decline in AMH secretion was observed in unilateral cryptorchid boys but it was not significant after age-adjusting.
However, the decrease in AMH and inhibin B levels was much more marked in the subgroup with bilateral cryptorchidism, even after adjusting for age, being twice as low as in the control group without cryptorchidism.
Correlation with Inhibin B and AMH in control and cryptorchid boys
In a next step, we wondered to explore the relationship between sertolian hormones and the potential impact of testes position (Fig. 3) . Inhibin B and AMH were not associated in Figure 1 Flow chart of study design. Figure 2 Reference levels compiled from literature for AMH and inhibin B of normal boys aged from 1 to 5 years. Y-axis projected position and area of the grey circles represent respectively the median or mean hormone level and the size of an age-group of normal boys. The dashed lines represent the linear regression of hormone levels according to age. For each panel, the size of the largest group is indicated. White circles represent control boys of this study.Upper panel. Normal AMH levels according to age. Fourteen age groups totaling 369 boys were extracted from two studies using in house immunoassays (Baker et al., 1990; Lee et al., 1996) and five studies using the IOT assay (Josso, 1995; Rey et al., 1999 Rey et al., , 2005 Guibourdenche et al., 2003; Aksglaede et al., 2010) . Their size varied from 5 to 117 boys. To convert AMH values to pmol/L, multiply by 7.14. Lower panel. Normal Inhibin B levels according to age. Ten age groups totalling 87 boys were extracted from three studies using the OBI immunoassay (Andersson et al., 1998; Byrd et al., 1998; Rey et al., 2005) . Their size varied from 2 to 22 boys.
controls (R² = 0.03, p = 0.36) but were positively associated in cryptorchid boys (R² = 0.36, p = 0.001). By splitting the cases, we observed that this association between inhibin B and AMH was because of bilateral cryptorchidism only (R² = 0.75, p = 0.001) as it was not found in boys with unilateral cryptorchidism (R² = 0.07, p = 0.309).
DISCUSSION
In this study, we found that blood levels of testosterone when quantifiable, AMH and inhibin B were significantly lower in cryptorchid boys compared with age-matched control group. Moreover, the hormonal pattern of Sertoli cell secretion was more altered in bilateral than in unilateral cryptorchid boys.
In the healthy male infant, it is well-known that the hypothalamo-pituitary-gonadal (HPG) axis is transiently activated during the first few months of life. This process, termed the mini-puberty of infancy, is followed by a relatively quiescent period until the HPG axis is reactivated in puberty. At approximately 3-month-old, a temporary surge of peripheral levels of gonadotropins occurs, followed by that of testosterone because of the temporary increase in the number of Leydig cells (Codesal et al., 1990) . Then, levels decrease and become very low or undetectable from approximately 6 months of age until the onset of puberty. The role of this first hormonal burst is not fully understood, but it seems to be involved in masculinizing the brain and obliterating the processus vaginalis after testicular descent is complete (Hutson et al., 2013) . It is also thought to be needed for the maturation of neonatal gonocytes to Ad(dark)-spermatogonia which later will be engaged in spermatogenesis (Hadziselimovic et al., 2005; Cortes et al., 2007) . Early studies have deciphered the relationship between mini-puberty and cryptorchidism. It has been found that blood LH and testosterone in infants with cryptorchidism are lower than those of age-matched control populations (Job et al., 1988; Raivio et al., 2003) . Moreover, these hormonal disparities come with cytological abnormalities in the cryptorchid testis, including reduction in the number of Leydig cells and less efficient transformation of gonocytes into Ad spermatogonia (Hadziselimovic et al., 2005) . Our findings regarding testosterone levels are consistent with these reports. Although the assays were performed at a mean age of 27 months and therefore late after the mini-puberty surge, we were still able to measure testosterone concentration 786 Andrology, 2017, 5, 783-789 in 10 boys (37%) in each group. We confirmed that cryptorchid infants presented significantly lower testosterone levels than those of the control group, suggesting a defect in the function and/or the number of Leydig cells. However, to definitely establish this assumption, it would be of interest to assess insulin-like factor 3 (INSL3). Unfortunately, the immunoassay was not available at the time of the study. Although Sertoli cells are the most representative cell population of the pre-pubertal testis, study of their function during mini-puberty was delayed because of the late emergence of specific immunoassays for AMH and inhibin B. It has been shown that Sertoli cells proliferate in response to the gonadotropin surge and abundantly secrete both AMH and inhibin B (Hutson et al., 2013) . However, they remain in an immature state and do not express androgen receptors, thus preventing the inhibitory effect of intra-testicular testosterone on AMH secretion (Boukari et al., 2009 ). Just after the testosterone peak, AMH and inhibin B sharply increase. Subsequently, inhibin B begins to decrease. The drop to a minimal, but still detectable, level is reached at 18 to 24 months of age (Andersson et al., 1998; Byrd et al., 1998) . AMH levels gradually decline from 1 year of age until puberty (Guibourdenche et al., 2003; Aksglaede et al., 2010) . By compiling data from the studies above and others, we established a framework for normal Sertoli cells secretion for non-cryptorchid boys between 1 and 5 year-old (Fig. 2) . First, we gained an assurance about our immunoassays results since inhibin B and AMH levels of our control group laid within this normal framework. Second, we revealed two features of Sertoli secretion during this period: (i) hormones levels were above their respective limits of quantification confirming that the immature testis is not completely quiescent despite a pause of the HPG axis (Rey, 1999; Chemes, 2001) ; (ii) AMH declines significantly during this period, whereas inhibin B remains stable. To the best of our knowledge, such discrepancy in both hormones kinetics has never been reported and deserves a confirmation in further longitudinal studies.
Numerous studies have investigated serum levels of sertolian hormones in cryptorchid boys and compared them with agematched control groups with descended testes. Some studies found no differences between the two groups for inhibin B (Christiansen et al., 2002; Pierik et al., 2009) or AMH (Pierik et al., 2009) , whereas other studies observed lower serum levels of inhibin B (Gaudino et al., 2008; Thorup et al., 2012) or AMH in cases than in controls (Yamanaka et al., 1991; Guibourdenche et al., 2003; Demircan et al., 2006; Matuszczak et al., 2012; Cortes et al., 2016) . Several reasons could explain such discrepancies: small set of patients, case mix of unilateral and bilateral cryptorchidism, large age range of the boys studied (from the early post-natal period to pre-pubertal age) including the minipuberty period, and the variety of immunoassays used in these studies. It is interesting to note that some abnormalities of the sertolian compartment have been reported in the prepubertal cryptorchid testis: fewer Sertoli cells per tubule than normal testes (Zivkovic & Hadziselimovic, 2009 ) abnormal morphology and cell degeneration hallmarks (Rune et al., 1992) . These findings are consistent with the peripheral low levels of AMH and inhibin B reported in cryptorchid boys by some studies.
In our series, we found that AMH and inhibin B levels were significantly diminished in cryptorchid boys with a narrow age range for both cases and controls and far away the mini-puberty hormonal surges. Moreover, a 20% decrease in AMH and inhibin B levels was observed in cases of unilateral cryptorchidism compared with a 50% decrease in cases of bilaterality. This decrease has been recently described by Thorup's group which reported worsened inhibin B and AMH secretion in case of bilateral cryptorchidism (Cortes et al., 2016) . This marked defect of Sertoli cells, as well as the decreased number of germ cells, may explain the compromised fertility found later in men born with bilateral cryptorchidism (Lee & Coughlin, 2001) .
The strength of our study is that we simultaneously measured three testicular hormones in similar and narrow age groups of cases and controls (around two-year old) when the HPG axis is supposed to be in pause (Neely et al., 1995; Andersson et al., 1998) . In normal boys, knowing that inhibin B and AMH kinetics are different (Fig. 2) and that no association was found between their blood levels (Fig. 3) , one can suppose that their secretions are independently regulated. This hypothesis is consistent with their differential ontogeny throughout childhood and the fact that AMH respond to a non-classical signaling pathway under the FSH receptor (Lukas-Croisier et al., 2003; Lasala et al., 2011) . Moreover, we found that in case group inhibin B and AMH became associated. Such result was very recently reported in cryptorchid boys aged between 1.2 and 13 years (Cortes et al., 2016) . Our finding that this strong and significant association was restricted to bilateral cryptorchidism (Fig. 3) is quite new. One can suppose that in the case of unilaterality, the endocrine secretion of the normal testis compensates that of the cryptorchid one and reduces the correlation. Overall, there is a quantitative and qualitative defect of the sertolian hormones secretion in bilateral cryptorchidism and several questions rise: what is the nature of this defect? Is it within the Sertoli cells and/or does it depend on their direct or indirect stimulation by gonadotropins? Is it because of a reduced number of Sertoli or germ cells? Does orchidopexy fix such a defect?
The weaknesses of the study include the absence of INSL3 assessment which would have strengthened our results on testosterone secretion in both groups of boys. It is noteworthy that this hormone has been implicated in the transabdominal phase of testis descent (Hutson et al., 2013) . Moreover, we could not report any data about gonadotropins levels or about number/morphology of germ cells and Sertoli cells within tubules. Noteworthy, no consensus exists among paediatric urologists regarding the role of testicular biopsy since it may provide valuable information for predicting both fertility potential and risk of cancer and be useful for fertility preservation (Faure et al., 2016) . The contribution of a systematical and precise anatomical report of the male tract during the orchidopexy should also be evaluated in further studies.
In conclusion, we found a simultaneous, clear and significant decrease in serum levels of AMH and inhibin B, and to a lesser extent of testosterone, in cryptorchid patients suggesting a functional defect of both Leydig and Sertoli cells. Moreover, the Sertoli cell endocrine deficiency seems to be more pronounced in bilateral cryptorchid boys. Further studies are needed to decipher the molecular background of such deficiency and we suggest that an endocrine profile, including at least gonadotropins, testosterone and AMH, should be systematically assessed in young boys before and after orchidopexy.
